Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions
Open Access
- 15 February 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 104 (6), 968-970
- https://doi.org/10.1038/bjc.2011.27
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomaliesJournal of Neuro-Oncology, 2010
- Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?The Lancet Oncology, 2010
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in GliomasJournal of Clinical Oncology, 2009
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasActa Neuropathologica, 2009
- IDH1 and IDH2 mutations in gliomas.2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and OligodendrogliomasThe American Journal of Pathology, 2009
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αScience, 2009
- IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumorsHuman Mutation, 2008
- Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFRGenes, Chromosomes and Cancer, 2003